Gyre Therapeutics (GYRE) had the highest return between October 13, 2023 and October 30, 2023 by a small-cap US stock, returning 53.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Gyre Therapeutics (GYRE) | 10/13/2023 - 10/30/2023 | 53.08% |
Byrna Technologies (BYRN) | 10/13/2023 - 10/30/2023 | 48.17% |
Vigil Neuroscience (VIGL) | 10/13/2023 - 10/30/2023 | 43.84% |
NioCorp Developments Ltd Common Stock (NB) | 10/13/2023 - 10/30/2023 | 38.7% |
Mobilicom Limited Warrants (MOBBW) | 10/13/2023 - 10/30/2023 | 29.95% |
LiveWire (LVWR) | 10/13/2023 - 10/30/2023 | 28.07% |
Aveanna Healthcare (AVAH) | 10/13/2023 - 10/30/2023 | 27.52% |
XPLR Infrastructure LP Unit (XIFR) | 10/13/2023 - 10/30/2023 | 25.31% |
Oncology Institute (TOI) | 10/13/2023 - 10/30/2023 | 23.38% |
Tourmaline Bio (TRML) | 10/13/2023 - 10/30/2023 | 21.57% |
Ramaco Resources (METC) | 10/13/2023 - 10/30/2023 | 20.79% |
Kohl's (KSS) | 10/13/2023 - 10/30/2023 | 20.22% |
Arrow Financial (AROW) | 10/13/2023 - 10/30/2023 | 20.04% |
Standard Biotools (LAB) | 10/13/2023 - 10/30/2023 | 19.88% |
Nerdwallet (NRDS) | 10/13/2023 - 10/30/2023 | 19.57% |
Clearpoint Neuro (CLPT) | 10/13/2023 - 10/30/2023 | 19.38% |
Bioventus (BVS) | 10/13/2023 - 10/30/2023 | 18.79% |
CuriosityStream (CURIW) | 10/13/2023 - 10/30/2023 | 18.45% |
Value Line (VALU) | 10/13/2023 - 10/30/2023 | 18.23% |
Stepan (SCL) | 10/13/2023 - 10/30/2023 | 17.62% |
Idaho Strategic Resources (IDR) | 10/13/2023 - 10/30/2023 | 17.58% |
Assembly Biosciences (ASMB) | 10/13/2023 - 10/30/2023 | 17.57% |
Rezolute (RZLT) | 10/13/2023 - 10/30/2023 | 17.33% |
E2open Parent (ETWO) | 10/13/2023 - 10/30/2023 | 17.14% |
Autolus Therapeutics (AUTL) | 10/13/2023 - 10/30/2023 | 16.74% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
